Syncona Limited is a Guernsey-based closed-ended investment company. The Company is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments). Syncona Investment Management Limited (SIML), acts as the Company’s alternative investment fund manager (investment manager).
Metrics to compare | SYNCS | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipSYNCSPeersSector | |
---|---|---|---|---|
P/E Ratio | 201.8x | 5.6x | 8.5x | |
PEG Ratio | 1.89 | 0.00 | 0.03 | |
Price/Book | 0.6x | 0.8x | 1.0x | |
Price / LTM Sales | 24.9x | 9.7x | 2.6x | |
Upside (Analyst Target) | 88.8% | 28.5% | 15.1% | |
Fair Value Upside | Unlock | 38.3% | 4.0% | Unlock |